Immatics NV (IMTX) is around the top of the Biotechnology industry according to InvestorsObserver. IMTX received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Immatics NV also achieved a score of 72 in the Biotechnology industry, putting it above 72 percent of Biotechnology stocks. Biotechnology is ranked 19 out of the 148 industries.
IMTX has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on IMTX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Immatics NV Stock Today?
Immatics NV (IMTX) stock is lower by -0.86% while the S&P 500 has gained 0.09% as of 12:23 PM on Thursday, Mar 28. IMTX is lower by -$0.10 from the previous closing price of $11.10 on volume of 70,904 shares. Over the past year the S&P 500 has risen 30.43% while IMTX has gained 46.22%. IMTX lost -$1.30 per share the over the last 12 months.
Click Here to get the full Stock Report for Immatics NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
